2018
DOI: 10.1016/j.ijscr.2018.05.021
|View full text |Cite
|
Sign up to set email alerts
|

Intraductal tubulopapillary neoplasm of the pancreas presenting as recurrent acute pancreatitis: A case report

Abstract: HighlightsIntraductal tubulopapillary neoplasms (ITPNs) is a rare malignant lesion.The patient was diagnosed as causing acute pancreatitis by ITPN.There are only 5 cases reported about ITPNs presenting as acute pancreatitis.It is important to diagnose that the cause of acute pancreatitis is ITPN.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 7 publications
0
5
0
Order By: Relevance
“…After applying our inclusion criteria, 68 articles were included in the systematic review (Figure S1). 11–78 …”
Section: Resultsmentioning
confidence: 99%
“…After applying our inclusion criteria, 68 articles were included in the systematic review (Figure S1). 11–78 …”
Section: Resultsmentioning
confidence: 99%
“…About one-third of patients were asymptomatic and ITPN was an incidental finding [ 2 , 5 8 , 10 , 19 ]. ITPN has also been associated with episodes of recurrent acute pancreatitis and should be considered in the differential diagnosis of idiopathic acute pancreatitis [ 20 ]. The intraluminal growth of the neoplasm inside the pancreatic duct may cause slow obstruction and obstructive chronic pancreatitis [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…Two of them were alive and disease-free 15 and 19 months after surgery [ 2 , 23 ], whereas the third was diagnosed with hepatic metastases in the fourth postoperative month [ 18 ]. There were also 4 reported cases of patients from Japan with pancreatic ITPN who received postoperatively S-1 (tegafur-gimeracil-oteracil potassium) [ 9 , 20 , 30 , 31 ]. S-1 plays a key role in the treatment of pancreatic cancer in Japan besides gemcitabine [ 32 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Regarding the "cork-of-wine bottle sign," Sakamoto et al noted the following: in the case where the tumor occupies the entire lumen of the pancreatic duct, MRI does not show the sign, it rather presents a ductal interruption. Therefore, the sign is not always a confirmed finding depending on the size and the degree of the lesion progression [14]. Consequently, the "two-tone-duct sign" and the "cork-of-wine bottle sign" cannot be considered useful findings in differentiating ITPN from PDAC.…”
Section: Methodsmentioning
confidence: 99%